Diabetes supplements market to reach $13.4b by 2031

The market is emphasising R&D investments amid rising demand for curative measures.

The global diabetes supplements market will reach $13.4b by 2031, growing at a 4.2% CAGR, said Transparency Market Research.

The sector’s expansion is driven by a rising awareness of curative measures against diabetes amidst the growing incidence of chronic diseases worldwide.

Moreover, the geriatric population presents an additional challenge for healthcare providers, who must ensure that supplements are effective and free from side effects.

In response, the market is placing greater emphasis on R&D investments.

“For instance, the companies are trying to bank on the research finding that vitamin D2 may aid in delaying symptoms of diabetes,” the report said.

Overall, the increased demand for diabetes prevention and treatment is expected to fuel the market’s growth within the forecast period.